News

The Movement Disorders Society has recently published Clinical Diagnostic Criteria for Parkinson’s disease. These new guidelines allow for the diagnosis of clinically established and clinical probable Parkinson’s disease, which will help reduce errors in clinical trials.

With Britain’s potential succession from the EU looming, scientific leaders in Europe are voicing their concerns that losing the UK would be a blow to clinical research.

The European Reference Networks aims to join the efforts of the best specialists in Europe to tackle complex or rare medical conditions. The goal is to create networks covering a specific disease with an emphasis on procedures or techniques related to treatment.

Major Depressive Disorder patients display a reduced ability to feel pleasant experiences known as Anhedonia. Such a feature provides difficulties when treating depression and engaging patients during clinical trials.

Drug safety surveillance, a core focus of clinical trials, can be influenced by subjective judgement, as this analysis of differing expert assessments of adverse drug reactions-and the reasons why-shows.

The success of a clinical trial depends on the sponsor’s ability to effectively execute its programs. Both quality of research and aptitude to complete the study on time determine the likelihood of advancement of a product to the next stage of development.

Clinerion and the The International Clinical Trial Center Network (ICN), a collection of academic and government-based research institutions, announced the adoption of Clinerion’s Patient Recruitment Service for ICN’s members. This system brings medical informatics solutions for protocol design, site selection and patient recruitment.

Mike Graziano, VP of Toxicology at Bristol-Myers Squibb, sits down with Moe Alsumidaie to discuss BioCelerate’s toxicology data sharing initiative.

Catch up on who has new jobs and recognitions that companies have received.

The Geriatric Medicines Working Party of the EFGCP is organizing a workshop on “Technology, Ethics and Older People in Clinical Research.” The goal is to explore what can be done to involve older people in clinical trials.